| 1 |
|
|
| 2 |
|
|
| 3 |
|
|
| 4 |
An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09)
(Ahn, MJ; Cho, JH; Sun, JM; Lee, SH; Ahn, JS; Park, K; Park, KU; Kang, EJ; Choi, YH; Kim, KH; An, HJ; Lee, HW, 2018)
|
|
| 5 |
|
|
| 6 |
Laparoscopic sentinel node navigation surgery versus laparoscopic standard gastrectomy with lymph node dissection in early gastric cancer: Results of postoperative morbidity and mortality from a multicenter randomized controlled trial (SENORITA trial)
(Ryu, KW; Kim, YW; Min, JS; An, JY; Yoon, HM; Eom, BW; Hur, H; Lee, YJ; Cho, GS; Park, YK; Jung, MR; Park, JH; Hyung, WJ; Jeong, SH; Nam, BH; Han, M; Kim, NH, 2018)
|
|
| 7 |
|
|
| 8 |
|
|
| 9 |
|
|
| 10 |
Investigating the feasibility of targeted next-generation sequencing to guide the treatment of head and neck squamous cell carcinoma.
(Keam, B; Lim, SM; Cho, SH; Hwang, IG; Ahn, MJ; Park, KU; Kim, JW; Ko, YH; Ahn, HK; Chun, SH; Hong, JH; Choi, J; Kang, EJ; Yun, T; Lee, KW; Kim, JS; Lee, HW; Kim, MK; Yun, HJ; Kim, H, 2018)
|
|
| 11 |
|
|
| 12 |
|
|
| 13 |
|
|
| 14 |
|
|
| 15 |
|
|
| 16 |
|
|
| 17 |
|
|
| 18 |
|
|
| 19 |
|
|
| 20 |
|
|
| 21 |
|
|
| 22 |
|
|
| 23 |
|
|
| 24 |
|
|
| 25 |
|
|
| 26 |
|
|
| 27 |
|
|
| 28 |
|
|
| 29 |
|
|
| 30 |
|
|
| 31 |
|
|
| 32 |
|
|
| 33 |
|
|
| 34 |
|
|
| 35 |
|
|
| 36 |
|
|
| 37 |
|
|
| 38 |
|
|
| 39 |
|
|
| 40 |
|
|
| 41 |
|
|
| 42 |
|
|
| 43 |
|
|
| 44 |
|
|
| 45 |
|
|
| 46 |
|
|
| 47 |
|
|
| 48 |
|
|
| 49 |
|
|
| 50 |
|
|
